Oseltamivir Pharmacokinetics, Dosing, and Resistance Among Children Aged <2 Years With Influenza

Background. Children <2 years of age are at high risk of influenza-related mortality and morbidity. However, the appropriate dose of oseltamivir for children <2 years of age is unknown. Methods. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group evalu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kimberlin, David W., Acosta, Edward P., Prichard, Mark N., Sánchez, Pablo J., Ampofo, Krow, Lang, David, Ashouri, Negar, Vanchiere, John A., Abzug, Mark J., Abughali, Nazha, Caserta, Mary T., Englund, Janet A., Sood, Sunil K., Spigarelli, Michael G., Bradley, John S., Lew, Judy, Michaels, Marian G., Wan, Wen, Cloud, Gretchen, Jester, Penelope, Lakeman, Fred D., Whitley, Richard J., Giles, Dusty, Cotton, Bari, Judy, Sharon, Cowie, Margaret, Francis, Jeanne, Evans, Candice, O'Donnell, Nan, Shiraishi, Ofelia Vargas, Latiolais, Lisa, Aymami, Valeri, Dole, Ken, Gaultier, Julie, Lofthus, Gerry, Kinnunen, Diane, Lacombe, Kirsten, Stellato, Nancy, Denlinger, Julie, Hingtgen, Sara, Mason, Christina, Jeffrey, Noreen
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2013
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3563309/
https://ncbi.nlm.nih.gov/pubmed/23230059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis765
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados